sub_visual

History

Total of five global license-out deals by 2020

2009~2012
R&D Platform Construction
  • Securing Apta-DC original technology
  • Patent Application for Diabetic nephropathy
  • Corporate Establishment
Step1
2013~2015
Pipeline Development
  • Anticancer Project with National Cancer Hospital (0.8M USD)
  • Healthcare Disease Conquest of Technology Project (1.1M USD)
  • High Tech & Business Development Project (7.2M USD)
Step2
2016~2017
Platform Expansion
  • Apta-16 License Out Deal
  • Apta-12 License Out Deal
  • Patent applications for eye diseases & liver diseases
  • Patent applications for Hematologic Malignancy
Step3
2018
Expand Global Business Opportunities
  • Completion of Phase I clinical trial in EU
  • wet-AMD Drug License Out Deal
Step4
Expand Global Business Opportunities
  • 2 Global License Out Deals
  • Initiate 4 clinical trials
  • Phase II : Diabetic Nephropathy · NASH (2 pipelines)
  • Phase I/II : AML· wet-AMD (2 pipelines)
Step5